Ero Copper to Release First Quarter 2024 Operating and Financial Results on May 7, 2024
April 11, 2024 17:05 ET
|
Ero Copper Corp.
VANCOUVER, British Columbia, April 11, 2024 (GLOBE NEWSWIRE) -- Ero Copper Corp. (TSX: ERO, NYSE: ERO) (the “Company”) will publish its first quarter 2024 operating and financial results on...
Goodfellow annonce ses résultats pour son premier trimestre terminé le 29 février 2024
April 11, 2024 17:00 ET
|
Goodfellow inc.
DELSON, Québec, 11 avr. 2024 (GLOBE NEWSWIRE) -- Goodfellow inc. (TSX : GDL) (la « Société » ou « Goodfellow ») annonce aujourd’hui ses résultats financiers pour le premier trimestre terminé le...
Goodfellow Reports Its Results for the First Quarter Ended February 29, 2024
April 11, 2024 17:00 ET
|
Goodfellow Inc.
GOODFELLOW REPORTS ITS RESULTS FOR THE FIRST QUARTER ENDED 02-29-2024. / GOODFELLOW ANNONCE SES RÉSULTATS POUR SON PREMIER TRIMESTRE TERMINÉ 02-29-2024
Aedifica NV/SA: 2023 Annual Report
April 04, 2024 02:00 ET
|
Aedifica
Download Aedifica’s 2023 Annual Report by clicking on the link below.
Attachments
Annual Report (EN)
Rapport Annuel (FR)
...
SuRo Capital Corp. Announces Expiration and Final Results of Tender Offer
April 03, 2024 09:00 ET
|
SuRo Capital Corp.
NEW YORK, April 03, 2024 (GLOBE NEWSWIRE) -- SuRo Capital Corp. (“SuRo Capital” or the “Company”) (Nasdaq: SSSS) today announced its final results from its modified “Dutch Auction” tender offer (the...
Annual results 2023: Record business generates solid results and confirms the attractiveness of the AFL model
April 02, 2024 09:18 ET
|
Agence France Locale
Annual results 2023: Record business generates solid results and confirms the attractiveness of the AFL model At 31 December 2023, the AFL Group reported a sharp improvement in results: The...
OKYO Pharma Announces Upcoming Presentation of OK-101 Phase 2 Data for Dry Eye Disease at Eyecelerator 2024, a Partner Meeting of the American Society for Cataract and Refractive Surgery
April 02, 2024 07:00 ET
|
OKYO Pharma LTD
LONDON and NEW YORK, April 02, 2024 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing innovative ocular therapies for the treatment of...
OKYO Pharma Announces OK-101 Successfully Achieved Statistical Significance for Multiple Signs and Symptoms of Dry Eye Disease including Ocular Pain Relief in its First-in-Human Phase 2 Trial of OK-101
March 22, 2024 07:00 ET
|
OKYO Pharma LTD
OKYO Pharma Announces OK-101 Successfully Achieved Statistical Significance for Multiple Signs and Symptoms of Dry Eye Disease including Ocular Pain Relief
Titanium Transportation Group Reports FY 2023 Financial Results
March 18, 2024 20:17 ET
|
Titanium Transportation Group Inc
Solid Q4 2023 results supported by 32% year-over-year growth in the trucking segment, reflecting revenue contribution from recent asset-based expansion into the United States.Second consecutive...
Ero Copper Reports Fourth Quarter and Full Year 2023 Operating and Financial Results
March 07, 2024 17:01 ET
|
Ero Copper Corp.
(all amounts in US dollars, unless otherwise noted) VANCOUVER, British Columbia, March 07, 2024 (GLOBE NEWSWIRE) -- Ero Copper Corp. (TSX: ERO, NYSE: ERO) (“Ero” or the “Company”) is pleased to...